Skip to content
Review

7-azaindole as privileged scaffold: Advances in drug design and structural modification

Jul 2026 · Medicinal Chemistry Research · Vol 35, pp. 1414 - 1453 · 0 citations · 157 references
Medicine

TL;DR

This review comprehensively summarizes medicinal chemistry advances based on the 7-azaindole scaffold from 2020 to 2026, and critically consolidates SAR trends, pinpoints the most frequently successful substitution vectors, and dissects recent clinical failures.

View source

Similar papers

Review Sep 2026

Pyrazinone Derivatives in Medicinal Chemistry: SAR Insights and Emerging Therapeutic Applications.

Pyrazinones remain a comparatively underexplored class of nitrogen heterocycles, despite their recurrence in bioactive natural products and their emergence as a privileged scaffold engaging viral polymerases, kinases, proteases, and G-protein-coupled receptors. Unlike prior reviews, typically confined to a single thera...

N. Agrawal, Priya Kushwah, Shilpi Pathak · 0 citations
Review Open access Sep 2026

Progress on quinoline-based antitumour agents: Mechanistic insights and optimization strategies (Review)

Quinoline derivatives are a class of heterocycles featuring a fused benzene-pyridine scaffold that have attracted notable interest in anticancer drug discovery owing to their favourable physicochemical properties, structural versatility and broad biological activities. Accumulating evidence indicates that quinoline-bas...

Yuwen Zeng, Yue Yan, Shi-Ye Wu et al. · 0 citations
Review Open access Aug 2026

The Pyrazolone Scaffold: A Privileged Motif for Molecular Hybridization in Drug Discovery

This review comprehensively summarizes recent advancements in the structural optimization of pyrazolone‐based compounds, highlighting how molecular hybridization drives polypharmacology against complex conditions, including neurodegenerative disorders, inflammation, metabolic syndromes, cancer, and infectious diseases.

Ke-Long Tang, Yao Liu, Jingning Luo et al. · 0 citations
Review Aug 2026

s-triazine-based Derivatives as Anticancer Agents.

An overview of the recent primary literature concerning the development of s-triazine-based antitumor agents is provided, focusing on the most potent compounds acting on specific molecular targets and discussing the structure-activity relationships (SARs), when available.

Doralice Giorgini, Jacopo Castagnoli, Lorenzo Filidei et al. · 0 citations
Open access Sep 2026

Novel Azo Sulfonamide Derivatives of 5-Sulfosalicylic Acid: Synthesis, Biological Evaluation, and Computational Profiling

The escalating crisis of multi-drug-resistant pathogens necessitates the development of novel therapeutic scaffolds with enhanced membrane permeability and multi-target inhibitory potential. This study describes the design, synthesis, and mechanistic evaluation of five novel azo-sulfonamide hybrids (4a–e) derived from...

Samar H. Ali, M. El-Zahed, Elham Negm et al. · 0 citations
Review Open access Aug 2026

Quinoline Scaffold in Drug Discovery: Synthetic Strategies, Therapeutic Applications, and Emerging Drug Candidates

The literature surveyed here shows that quinoline derivatives continue to serve as a versatile scaffold for generating new leads, linking established synthetic chemistry with current mechanistic and computational approaches.

A. El-mrabet, A. Haoudi, Amine Ez‐zoubi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.